Navigation Links
How 'IAP antagonist' chemicals kill tumors
Date:11/15/2007

. The IAP proteins were later found in other organisms, from flies to mammals. The proteins were also shown to rise in human cancer, making them attractive targets for the development of novel cancer therapeutics. Scientists have therefore sought to design molecules that could antagonize IAPs, taking the lead from natural IAP antagonists.

Vucics group now shows that an IAP antagonist leads cIAPs to be marked for degradation by cellular components known as proteosomes. This is an amazingly rapid occurrence, happening within two minutes in cells in culture after exposure to the compound, said Vishva Dixit, who is also from Genentech.

They found that treatment with the IAP antagonist led to the activation of a NF-"B pathway that produces another protein, called tumor necrosis factor (TNFa). TNFa comes back and binds its receptor, triggering unimpeded apoptosis and killing cancer cells, Vucic said.

Likewise, Silkes team showed that synthetic and naturally occurring IAP antagonists kill susceptible tumor cells through their action on cIAP1, resulting in NF-"B activation, which drives TNFa production and initiates tumor cell death. Silke noted that the congruence between the findings of the two studies is a really good sign.

These studies show the potential for these drugs, although there is a long road to go, Silke added. It also demonstrates an important principle: If you can understand how something works through basic scientific discoveries, then you can really start to make targeted tumor therapies. We can begin to understand how tumors live and how to make them die.

Vucic said that a phase I clinical trial designed to test the safety of one of their IAP antagonist compounds in human patients is already underway.


'/>"/>

Contact: Cathleen Genova
cgenova@cell.com
617-397-2802
Cell Press
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Rohm and Haas to Webcast Presentation at Credit Suisse Chemicals Conference
2. National Academies advisory: genes and toxic chemicals
3. Genomic technologies to identify toxic chemicals should be developed
4. Researchers study potential health benefits of natural chemicals in muscadine grape seeds
5. Study reveals huffing household chemicals connected to teen suicide
6. Marijuana-like brain chemicals work as antidepressant
7. Hazardous Advanced Micro Devices (A.M.D.) Clean Room Chemicals Caused Multiple Birth Defects, Lawsuit Alleges
8. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
9. Study suggests brain tumors need treatment with multiple targeted drugs
10. Bright tumors, dim prospects
11. Genomic profiling of lung tumors helps doctors choose most effective treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2008)... Survey also reveals less than 5% trust magazines...RK, May 20 /PRNewswire-USNewswire/ -- The Physicia...jectablesafety.org ) and the health and,beauty com...day released,findings of a joint survey reporting ...ties are safe, and only 58% of consumers feel FDA ...
(Date:5/20/2008)... CHELMSFORD, Mass., May 20 /PRNewswire-FirstCall/...), a leading provider of specialized,high-perform..., and signal,processing applications, announced th...any,s business on Thursday, May 29, 2008 at the Co...ference. The Conference will be,held at the New Yo...
(Date:5/20/2008)...To advance underdeveloped approaches to designing ...f Allergy and Infectious Diseases (NIAID), part of... new program to foster the study of B cells, immun...ity to neutralize HIV. The $15.6 million, five-yea...c foundation of HIV vaccine research through a net...
(Date:5/20/2008)... CHAPEL HILL, N.C., May 20 /PRNewswire/ -- New re...isition integration and competitive,intelligence d...able in the,Best Practice Database, an online rese... firm Best Practices, LLC., To review sample key ...,landing page with links to each study at this add...
Breaking Medicine News(10 mins):Health News:New Survey Suggests That Consumers Are Naive to the Risk of Botox Parties and the Importance of FDA Approval for Cosmetic Injectables 2Health News:New Survey Suggests That Consumers Are Naive to the Risk of Botox Parties and the Importance of FDA Approval for Cosmetic Injectables 3Health News:New Survey Suggests That Consumers Are Naive to the Risk of Botox Parties and the Importance of FDA Approval for Cosmetic Injectables 4Health News:Mercury Computer Systems to Present at the Cowen and Company 20/20 Technology-Media-Telecom Conference on May 29, 2008 2Health News:NIAID to advance B-cell approach to HIV vaccines 2Health News:NIAID to advance B-cell approach to HIV vaccines 3Health News:Best Practice Database Adds Research on Merger Integration and Competitive Intelligence 2
... a patient’s specific culture into consideration c...e incidence of diabetes-related complications over...er management results in reduced long-term complic...utation and nerve damage,” said lead researcher To...
...an, who was rushed to a city hospital here Sunday ...er and recovering from severe exertion, hospital s...but will be kept under observation for the next tw...ital dean N. Trivedi. Saif, 36, was rushed to Li...
...ng Victorian hospital staff could be putting the h...n and control experts. A study published in the ...n half of Victorian health workers in public hospi...ugh the vaccine is provided free through the natio...
...ins is under pressure- he is asked to respond to a... Muckamore Abbey Hospital, which ‘cares’ for peopl...ckamore Abbey Hospital, which houses around 100 ad...der police investigation. The issue came about wh...
Other Medicine News:Health News:Culturally Specific Diabetes Management Helps Low-Income Patients 2
(Date:5/20/2008)...ice leads to 100% patient response ... /- BARRX Medical, Inc., a global,tec...day announced the,publication of two related Europ...r early esophageal cancer and pre-cancerous dyspla...n therapy with the HALO ablation,system. Barrett,s...
(Date:5/20/2008)...l/ -- Delcath Systems, Inc.,(Nasdaq: DCTH ) annou...tive,Officer, provided an update on enrollment num...rial today at a gathering of financial and healthc...w 5th Annual Global,Healthcare Conference., Mr. T... for the Phase,III clinical trial of the Company,s...
(Date:5/19/2008)... MORE SCIENCE SUPPORTING THE, THEORY THAT VACCINE...ewswire-USNewswire/ -- A primate model for autism,...s unveiled at the,International Meeting For Autism...scores the critical need for studies into vaccine ...n of autistic children. The National,Autism Associ...
(Date:5/19/2008)...ss Shionogi Phase 3 results on .../- InterMune, Inc.,(Nasdaq:...development of,pirfenidone for the treatment of id...st Track" designation from the U.S. Food and Drug,...that the FDA reserves for,a drug intended to treat...
Breaking Medicine Technology:Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination 2Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination 3Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited 2Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited 3UPDATE: Infant Primates Given Vaccines on U.S. Children's Immunization Schedule Develop Behavioral Symptoms of Autism 2InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA 2InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA 3Global Health and Business Leaders Announce 36 Month Effort to Expand Malaria Control in Africa 3B 3 5 Million Lives Could be Saved in Five Years Stu 10123 1Global Health and Business Leaders Announce 36 Month Effort to Expand Malaria Control in Africa 3B 3 5 Million Lives Could be Saved in Five Years Stu 10123 2Global Health and Business Leaders Announce 36 Month Effort to Expand Malaria Control in Africa 3B 3 5 Million Lives Could be Saved in Five Years Stu 10123 3Global Health and Business Leaders Announce 36 Month Effort to Expand Malaria Control in Africa 3B 3 5 Million Lives Could be Saved in Five Years Stu 10123 4Metabolic syndrome affects nearly 1 in 10 US teens 10120 1Metabolic syndrome affects nearly 1 in 10 US teens 10120 2Metabolic syndrome affects nearly 1 in 10 US teens 10120 3NuVasive Announces Preliminary Unaudited Full Year 2007 Financial Results 10117 1NuVasive Announces Preliminary Unaudited Full Year 2007 Financial Results 10117 2NuVasive Announces Preliminary Unaudited Full Year 2007 Financial Results 10117 3Bill Germanakos and Hollie Self Bring The Biggest Loser Million Pound Tour Presented by MSN to Arizona Mills Mall 10114 1Bill Germanakos and Hollie Self Bring The Biggest Loser Million Pound Tour Presented by MSN to Arizona Mills Mall 10114 2
...ind these data reassuring", PHILADELPHIA, June 05,...id today that findings from an interim analysis,of...mes and,Regulation of glycemia in Diabetes), a pro...etermine cardiovascular outcomes in more,than 4,40...ence to,the overall cardiovascular safety profile ...
...--Jun 5, 2007 - Elixir,Pharmaceuticals, Inc., anno...n antagonism as a potential method for regulating,...ood glucose. The,data were presented in poster ses... Annual Meeting, being held in Toronto,Canada. El...at and,prevent metabolic disease, as well as preve...
Other Medicine Technology:Interim Data From RECORD Study Show No Significant Difference,Between Avandia and Standard Therapy in Risk of Cardiovascular,Hospitalization or Death 2Interim Data From RECORD Study Show No Significant Difference,Between Avandia and Standard Therapy in Risk of Cardiovascular,Hospitalization or Death 3Interim Data From RECORD Study Show No Significant Difference,Between Avandia and Standard Therapy in Risk of Cardiovascular,Hospitalization or Death 4Interim Data From RECORD Study Show No Significant Difference,Between Avandia and Standard Therapy in Risk of Cardiovascular,Hospitalization or Death 5Elixir Pharmaceuticals Presents Additional Preclinical Data,Demonstrating the Potential of Ghrelin Antagonism to Regulate,Metabolism, Body Weight and Glycemic Control 2Elixir Pharmaceuticals Presents Additional Preclinical Data,Demonstrating the Potential of Ghrelin Antagonism to Regulate,Metabolism, Body Weight and Glycemic Control 3Elixir Pharmaceuticals Presents Additional Preclinical Data,Demonstrating the Potential of Ghrelin Antagonism to Regulate,Metabolism, Body Weight and Glycemic Control 4
Stainless steel threaded Steinman Pins available in point types A,D, E, and F.
Swanson Finger Pins are stainless steel and available in one length and three diameters.
Instera pins are sterile packaged and are available in 0.89, 1.1, 1.5, and 2.0mm diameters.
...ng Jet-X Pin products are available: , 5mm x 30mm ...6 Cannulated H-Pin , 5mm x 50mm Traction Pin ...SST Half Pin , TI 5mm Half Pin , TI 5mm x ...in , TI Half Pin , TiN 5 x 40, 1.6 Cann ...
Medicine Products: